Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)

SHE:300485 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 26, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	5,472	3,376	5,101	5,770	6,353	7,109
Market Cap Growth	68.30%	-33.80%	-11.60%	-9.17%	-10.64%	62.97%
Enterprise Value	3,861	1,875	4,044	4,529	5,091	5,774
Last Close Price	11.36	7.01	10.56	11.85	12.86	14.31
PE Ratio	66.75	-	49.56	28.19	15.79	45.90
Forward PE	-	27.14	27.14	27.14	27.14	27.14
PS Ratio	13.60	8.11	10.70	7.86	6.05	6.50
PB Ratio	1.59	1.00	1.47	1.69	1.94	2.50
P/TBV Ratio	1.64	1.03	1.52	1.75	2.01	2.61
P/FCF Ratio	-	96.89	-	85.93	46.25	48.73
P/OCF Ratio	89.77	24.83	240.48	52.25	34.66	26.96
EV/Sales Ratio	9.60	4.50	8.49	6.17	4.85	5.28
EV/EBITDA Ratio	69.94	27.06	468.15	63.22	33.70	35.96
EV/EBIT Ratio	-	83.53	-	186.82	53.36	46.72
EV/FCF Ratio	-131.13	53.80	-	67.45	37.06	39.58
Net Debt / Equity Ratio	-0.48	-0.46	-0.34	-0.33	-0.39	-0.41
Net Debt / EBITDA Ratio	-29.81	-22.69	-135.86	-15.66	-8.58	-7.35
Net Debt / FCF Ratio	55.53	-45.10	37.02	-16.70	-9.43	-8.09
Asset Turnover	0.11	0.12	0.13	0.21	0.33	0.38
Inventory Turnover	1.71	1.52	1.44	1.62	1.29	1.08
Quick Ratio	20.86	19.79	23.91	16.15	15.75	9.66
Current Ratio	21.80	20.86	26.30	17.62	17.30	10.93
Return on Equity (ROE)	2.18%	-2.24%	2.80%	6.05%	12.88%	5.44%
Return on Assets (ROA)	0.16%	0.39%	-0.69%	0.43%	1.86%	2.67%
Return on Invested Capital (ROIC)	0.39%	1.09%	-1.37%	0.90%	4.70%	6.72%
Return on Capital Employed (ROCE)	0.30%	0.60%	-1.10%	0.70%	2.90%	4.30%
Earnings Yield	1.48%	-2.04%	2.02%	3.55%	6.33%	2.18%
FCF Yield	-0.54%	1.03%	-0.62%	1.16%	2.16%	2.05%
Dividend Yield	-	-	0.21%	0.73%	1.31%	0.45%
Payout Ratio	-	-	40.22%	39.50%	7.78%	19.38%
Buyback Yield / Dilution	4.35%	-0.35%	-2.93%	0.58%	1.07%	-0.96%
Total Shareholder Return	4.35%	-0.35%	-2.72%	1.30%	2.38%	-0.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.